| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/10/2002 | WO2001036615A3 Permanent amniocyte cell line, the production thereof and its use for producing gene transfer vectors |
| 01/10/2002 | WO2001036474A3 Srik a novel cell cycle protein associated with rip3 |
| 01/10/2002 | WO2001036458A3 Drosophila ced-6 homologue |
| 01/10/2002 | WO2001036452A3 Heteroclitic analogs of class i epitodes |
| 01/10/2002 | WO2001034835A3 Method for the production of biopolymers with modified properties |
| 01/10/2002 | WO2001034813A3 Plant riboflavin synthase gene and inhibitors |
| 01/10/2002 | WO2001034778A3 Human atpases and polynucleotides encoding the same |
| 01/10/2002 | WO2001034649A3 Compositions and methods for treating autoimmune diseases and transplant rejections |
| 01/10/2002 | WO2001034302A3 Biochannel assay for hybridization with biomaterial |
| 01/10/2002 | WO2001029217A3 Novel polypeptides and polynucleotides encoding same |
| 01/10/2002 | WO2001023580A3 Polyhydroxyalkanoate synthase genes |
| 01/10/2002 | WO2001018050A3 T2r taste receptor family |
| 01/10/2002 | WO2001017344A3 A method of transgenic fowl construction |
| 01/10/2002 | WO2001016305A3 Nucleotide sequences encoding an insectidal protein complex from serratia |
| 01/10/2002 | WO2001012664A3 Notch receptor ligands and uses thereof |
| 01/10/2002 | WO2001011048B1 Therapeutic polypeptides and methods for using same |
| 01/10/2002 | WO2001000829A3 Human endogenous retrovirus in breast cancer |
| 01/10/2002 | WO2001000806A3 Dna's encoding proteins with signal peptides |
| 01/10/2002 | WO2001000661A3 Carnitine carrier related protein-1 |
| 01/10/2002 | WO2000075347A3 Tet repressor-based transcriptional regulatory proteins |
| 01/10/2002 | WO2000075300A3 Methods for manipulating the avian genome |
| 01/10/2002 | WO2000066162A9 Mutant human cd80 and compositions for and methods of making and using the same |
| 01/10/2002 | WO2000055332A3 Human regulators of intracellular phosphorylation |
| 01/10/2002 | US20020004944 Transgenic plant; for use in the prevention of microorganism infection in plants |
| 01/10/2002 | US20020004943 Nucleotide sequences coding plant polypeptide; for use in the generation of transgenic plants of preferential phenotypes |
| 01/10/2002 | US20020004940 Novel defense induced genes and uses thereof |
| 01/10/2002 | US20020004939 Methods for identifying transgenic plants using morphological markers |
| 01/10/2002 | US20020004938 Models of prion disease |
| 01/10/2002 | US20020004937 Method for detecting an aberrant animal-derived prion gene and a prion gene modified mouse which exhibits heart anomalies |
| 01/10/2002 | US20020004706 Apparatus and method for automated protein design |
| 01/10/2002 | US20020004658 Multiple beam laser sculpting system and method |
| 01/10/2002 | US20020004593 Methods of making modified nucleosides |
| 01/10/2002 | US20020004592 Method for amplifying full length single strand polynucleotide sequences |
| 01/10/2002 | US20020004591 Novel human proteases and polynucleotides encoding the same |
| 01/10/2002 | US20020004590 Acid phosphatase |
| 01/10/2002 | US20020004587 Antibody for use in the treatment of cancer; antitumor agents |
| 01/10/2002 | US20020004586 Prion-binding activity in serum and proteins |
| 01/10/2002 | US20020004585 Antibody for use in the detection of preferential enzyme expression; for use as tool in treatment and detection of enzyme defects; for treatment autoimmune disease, inflammation, sepsis, diabetes, kidney defects and cancer |
| 01/10/2002 | US20020004581 Polypeptide; for use in te diagnosis and treatment of microorganismal infections; bactericides |
| 01/10/2002 | US20020004580 Polypeptide; for use in the diagnosis and treatment of microorganismal infections; bactericides |
| 01/10/2002 | US20020004531 Nitrone inhibition of cancer development |
| 01/10/2002 | US20020004490 Antisense modulation of Fas mediated signaling |
| 01/10/2002 | US20020004489 Retinoid receptor interacting polynucleotides, polypeptides, and antibodies |
| 01/10/2002 | US20020004488 Gene therapy |
| 01/10/2002 | US20020004487 Novel erythromycins and process for their preparation |
| 01/10/2002 | US20020004482 Treatment of acute lung injury and fibrosis with antagonists of avbeta6 |
| 01/10/2002 | US20020004243 Method for introducing recessive properties into the genetic background of industrial baker's yeast |
| 01/10/2002 | US20020004242 Plasmids for construction of eukaryotic viral vectors |
| 01/10/2002 | US20020004240 Method and system for introducing a gene into a human stem cell |
| 01/10/2002 | US20020004239 Nucleotide sequences coding genetically engineered polypeptide; for use in the treatment of mammary gland cancer |
| 01/10/2002 | US20020004232 Nucleotide sequences coding proteins for use in the treatment and prevention of cancer |
| 01/10/2002 | US20020004231 Microorganism for use in the generation of preferential amino acid |
| 01/10/2002 | US20020004229 Generating antibiotic; obtain vector, transform cell, express preferential enzyme in cells, recover antibiotic |
| 01/10/2002 | US20020004226 Soluble LDL receptor, its production and use |
| 01/10/2002 | US20020004225 Activating bone development in mammals; prepare activator, adminster to mammal, monitor mammal for bone development |
| 01/10/2002 | US20020004223 Polypeptide; for use in the diagnosis and treatment of cancer |
| 01/10/2002 | US20020004221 Apoptosis modulator; for use in prevention of apoptosis; for use in evaluation of eye develpment |
| 01/10/2002 | US20020004215 Adjusting preferental particles to generate signal; mix ligand and marker, enzyme, incubate, allow binding, detect signal |
| 01/10/2002 | US20020004211 Methods for isolating and characterizing endogenous mRNA-protein (mRNP) complexes |
| 01/10/2002 | US20020004203 Reduced activity of polymerase chain reactions |
| 01/10/2002 | US20020004202 In vivo screen using chemical inducers of dimerization |
| 01/10/2002 | US20020004195 Synthetic transcriptional modulators and uses thereof |
| 01/10/2002 | US20020004193 Novel MP-7 protein and nucleic acid molecules and uses therefor |
| 01/10/2002 | US20020004076 Oral immunology using plant product containing a non-enteric pathogen antigen |
| 01/10/2002 | US20020004048 Hepatitis C virus asialoglycoproteins |
| 01/10/2002 | US20020004047 DNA encoding a novel RG1 polypeptide |
| 01/10/2002 | US20020004043 Cellular and animal models for diseases associated with altered mitochondrial function |
| 01/10/2002 | US20020004042 Gene therapy for pulmonary edema using adenovirus vectors encoding a beta2adrenergic receptor gene |
| 01/10/2002 | US20020004040 Complementary adenoviral vector systems and cell lines |
| 01/10/2002 | US20020003623 Sample chip analyzing device and method for analyzing the same |
| 01/10/2002 | DE10128980A1 Genetically modified T cells, useful e.g. for inhibiting allogenic transplant rejection, produced by incubating recipient and donor T cells then transducing with immunomodulatory gene |
| 01/10/2002 | DE10031932A1 Calpain-Protease 12 Calpain protease 12 |
| 01/10/2002 | DE10031236A1 Verwendung von Carbonsäuren und anderen Additiven in Kombination mit kationischen Verbindungen zur Stabilisierung von Nukleinsäuren in biologischen Materialien Use of carboxylic acids and other additives in combination with cationic compounds to stabilize the nucleic acids in biological materials |
| 01/10/2002 | DE10030976A1 Production of unsaturated fatty acids, useful e.g. in nutrition, cosmetics or pharmaceuticals, in organisms transformed with Physcomitrella patens delta-6-desaturase nucleic acid |
| 01/10/2002 | DE10030647A1 Preparing fine chemicals, particularly Vitamins E and K, useful as antioxidants e.g. in foods or medicine, by growing organisms with altered shikimate biosynthesis pathway |
| 01/10/2002 | DE10022334A1 Proteinproduktion in der Hefe Arxula Protein production in yeast Arxula |
| 01/10/2002 | CA2630062A1 Methods for treating graft versus host disease and immune disorders associated with rejection using a soluble ctla4 molecule |
| 01/10/2002 | CA2585012A1 Antibodies that immunospecifically bind to blys |
| 01/10/2002 | CA2416292A1 Transgenic mice containing targeted gene disruptions |
| 01/10/2002 | CA2416191A1 Novel lipase |
| 01/10/2002 | CA2415258A1 Devices and methods for carrying out chemical reactions using photogenerated reagents |
| 01/10/2002 | CA2415125A1 Polynucleotide sequence assay |
| 01/10/2002 | CA2415123A1 Novel fibroblast growth factors and nucleic acids encoding same |
| 01/10/2002 | CA2415075A1 Novel secreted proteins |
| 01/10/2002 | CA2414995A1 Inhibitory pas domain protein (ipas) and screening methods related to angiogenesis and tumor progression |
| 01/10/2002 | CA2414884A1 Immunisation against chlamydia pneumoniae |
| 01/10/2002 | CA2414727A1 Elicitor from cladosporium |
| 01/10/2002 | CA2414672A1 Novel human serine-threonine kinase |
| 01/10/2002 | CA2414650A1 Isolation of a cell-specific internalizing peptide that infiltrates tumor tissue for targeted drug delivery |
| 01/10/2002 | CA2414626A1 A method for extracting quantitative information relating to interactions between cellular components |
| 01/10/2002 | CA2414596A1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/10/2002 | CA2414592A1 Calpain protease 12 |
| 01/10/2002 | CA2414497A1 Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof |
| 01/10/2002 | CA2414328A1 Chimeric promoters for controlling expression in smooth muscle cells |
| 01/10/2002 | CA2413756A1 Dna encoding human serine protease d-g |
| 01/10/2002 | CA2413753A1 Antifungal compounds and methods of use |
| 01/10/2002 | CA2413715A1 Grf2-binding proteins and applications thereof |
| 01/10/2002 | CA2413262A1 B7-like molecules and uses thereof |
| 01/10/2002 | CA2413237A1 Alteration of cell membrane for new functions |
| 01/10/2002 | CA2413186A1 Extracellular matrix and cell adhesion molecules |